{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:52:45Z","timestamp":1791186765383,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.phrs.2013.08.008","type":"journal-article","created":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T10:01:38Z","timestamp":1378029698000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["FXR mediates a chromatin looping in the GR promoter thus promoting the resolution of colitis in rodents"],"prefix":"10.1016","volume":"77","author":[{"given":"Barbara","family":"Renga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"D\u2019Amore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mencarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Carino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Sepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Zampella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Distrutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Fiorucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2013.08.008_bib0005","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3109\/08916931003674709","article-title":"Inflammatory bowel disease\u2014from mechanisms to treatment strategies","volume":"43","author":"Melgar","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.phrs.2013.08.008_bib0010","first-page":"538","article-title":"How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering","volume":"S0303\u20137207","author":"Ratman","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.phrs.2013.08.008_bib0015","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nri2748","article-title":"Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells","volume":"10","author":"Glass","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.phrs.2013.08.008_bib0020","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1053\/gast.2001.26279","article-title":"The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study","volume":"121","author":"Faubion","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phrs.2013.08.008_bib0025","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/gut.35.3.360","article-title":"Frequency of glucocorticoid resistance and dependency in Crohn's disease","volume":"35","author":"Munkholm","year":"1994","journal-title":"Gut"},{"key":"10.1016\/j.phrs.2013.08.008_bib0030","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1023\/A:1026644711530","article-title":"Decreased corticosensitivity in quiescent Crohn's disease: an ex vivo study using whole blood cell cultures","volume":"44","author":"Franchimont","year":"1999","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.phrs.2013.08.008_bib0035","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s002280050512","article-title":"Pharmacokinetics of intravenous methylprednisolone and oral prednisone in paediatric patients with inflammatory bowel disease during the acute phase and in remission","volume":"54","author":"Faure","year":"1998","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.phrs.2013.08.008_bib0040","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1046\/j.1365-2036.2003.01802.x","article-title":"Glucocorticoid receptor expression in inflammatory bowel disease: evidence for a mucosal down-regulation in steroid-unresponsive ulcerative colitis","volume":"19","author":"Raddatz","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.phrs.2013.08.008_bib0045","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1046\/j.1365-2362.1999.00460.x","article-title":"Glucocorticoid receptors are down-regulated in inflamed colonic mucosa but not in peripheral blood mononuclear cells from patients with inflammatory bowel disease","volume":"29","author":"Rogler","year":"1999","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.phrs.2013.08.008_bib0050","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.4049\/jimmunol.0803978","article-title":"The bile acid receptor FXR is a modulator of intestinal innate immunity","volume":"183","author":"Vavassori","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.phrs.2013.08.008_bib0055","doi-asserted-by":"crossref","first-page":"e54472","DOI":"10.1371\/journal.pone.0054472","article-title":"The bile acid sensor FXR is required for immune-regulatory activities of TLR-9 in intestinal inflammation","volume":"8","author":"Renga","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2013.08.008_bib0060","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1096\/fj.11-195701","article-title":"Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition","volume":"26","author":"Renga","year":"2012","journal-title":"FASEB J"},{"key":"10.1016\/j.phrs.2013.08.008_bib0065","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1021\/jm201004p","article-title":"Conicasterol E, a small heterodimer partner sparing farnesoid-X-receptor modulator endowed with a pregnane-X-receptor agonistic activity, from the marine sponge Theonella swinhoei","volume":"55","author":"Sepe","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.phrs.2013.08.008_bib0070","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbagrm.2011.01.008","article-title":"Farnesoid X receptor suppresses constitutive androstane receptor activity at the multidrug resistance protein-4 promoter","volume":"1809","author":"Renga","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.phrs.2013.08.008_bib0075","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nmeth823","article-title":"The three \u2018C\u2019 s of chromosome conformation capture: controls, controls, controls","volume":"3","author":"Dekker","year":"2006","journal-title":"Nat Methods"},{"key":"10.1016\/j.phrs.2013.08.008_bib0080","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/nprot.2007.243","article-title":"Quantitative analysis of chromosome conformation capture assays (3C-qPCR)","volume":"2","author":"Hag\u00e8ge","year":"2007","journal-title":"Nat Protoc"},{"key":"10.1016\/j.phrs.2013.08.008_bib0085","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1210\/me.2010-0436","article-title":"Differential regulation and function of 5\u2032-untranslated GR-exon 1 transcripts","volume":"25","author":"Bockm\u00fchl","year":"2011","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.phrs.2013.08.008_bib0090","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2005.06.029","article-title":"Molecular determinants of crosstalk between nuclear receptors and toll-like receptors","volume":"122","author":"Ogawa","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2013.08.008_bib0095","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1210\/er.2002-0006","article-title":"The interplay between the glucocorticoid receptor and nuclear factor-\u03baB or activator protein-1: molecular mechanisms for gene repression","volume":"24","author":"De Bosscher","year":"2003","journal-title":"Endocr Rev"},{"key":"10.1016\/j.phrs.2013.08.008_bib0100","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1210\/er.20.4.435","article-title":"Molecular control of immune\/inflammatory responses: interactions between nuclear factor-\u03baB and steroid receptor-signaling pathways","volume":"20","author":"McKay","year":"1999","journal-title":"Endocr Rev"},{"key":"10.1016\/j.phrs.2013.08.008_bib0105","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.2174\/0929867013371950","article-title":"Vitamin D analogs: mechanism of action and therapeutic applications","volume":"8","author":"Nagpal","year":"2001","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.phrs.2013.08.008_bib0110","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/384039a0","article-title":"The PPAR\u03b1-leukotriene B4 pathway to inflammation control","volume":"384","author":"Devchand","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2013.08.008_bib0115","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/35154","article-title":"PPAR\u03b3 agonists inhibit production of monocyte inflammatory cytokines","volume":"391","author":"Jiang","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2013.08.008_bib0120","doi-asserted-by":"crossref","first-page":"6503","DOI":"10.4049\/jimmunol.164.12.6503","article-title":"Peroxisome proliferator-activated receptor-\u03b3 activators inhibit IFN\u03b3-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells","volume":"164","author":"Marx","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.phrs.2013.08.008_bib0125","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/34178","article-title":"The peroxisome proliferator-activated receptor-\u03b3 is a negative regulator of macrophage activation","volume":"391","author":"Ricote","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2013.08.008_bib0130","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1097-2765(03)00384-8","article-title":"Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism","volume":"12","author":"Castrillo","year":"2003","journal-title":"Mol Cell"},{"key":"10.1016\/j.phrs.2013.08.008_bib0135","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.cell.2004.09.032","article-title":"LXR-dependent gene expression is important for macrophage survival and the innate immune response","volume":"119","author":"Joseph","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2013.08.008_bib0140","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.bbadis.2009.04.004","article-title":"Reciprocal regulation of the bile acid-activated receptor FXR and the interferon-gamma-STAT-1 pathway in macrophages","volume":"1792","author":"Renga","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.phrs.2013.08.008_bib0145","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00011-010-0306-1","article-title":"SHP-dependent and -independent induction of peroxisome proliferator-activated receptor-\u03b3 by the bile acid sensor farnesoid X receptor counter-regulates the pro-inflammatory phenotype of liver myofibroblasts","volume":"60","author":"Renga","year":"2011","journal-title":"Inflamm Res"},{"key":"10.1016\/j.phrs.2013.08.008_bib0150","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1172\/JCI41681","article-title":"LXR\u03b2 is required for glucocorticoid-induced hyperglycemia and hepatosteatosis in mice","volume":"121","author":"Patel","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.phrs.2013.08.008_bib0155","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1126\/science.272.5266.1336","article-title":"An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors","volume":"272","author":"Seol","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.phrs.2013.08.008_bib0160","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S1097-2765(00)00051-4","article-title":"A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis","volume":"6","author":"Goodwin","year":"2000","journal-title":"Mol Cell"},{"key":"10.1016\/j.phrs.2013.08.008_bib0165","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1210\/me.2002-0120","article-title":"Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor","volume":"17","author":"Pineda Torra","year":"2003","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.phrs.2013.08.008_bib0170","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1124\/mol.106.023820","article-title":"The farnesoid X receptor promotes adipocyte differentiation and regulates adipose cell function in vivo","volume":"70","author":"Rizzo","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.phrs.2013.08.008_bib0175","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.bcp.2013.01.001","article-title":"FXR-dependent and -independent interaction of glucocorticoids with the regulatory pathways involved in the control of bile acid handling by the liver","volume":"85","author":"Rosales","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.phrs.2013.08.008_bib0180","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/hep.23450","article-title":"Genome-wide tissue-specific farnesoid X receptor binding in mouse liver and intestine","volume":"51","author":"Thomas","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2013.08.008_bib0185","doi-asserted-by":"crossref","first-page":"6007","DOI":"10.1093\/nar\/gkq397","article-title":"Genome-wide interrogation of hepatic FXR reveals an asymmetric IR-1 motif and synergy with LRH-1","volume":"38","author":"Chong","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.phrs.2013.08.008_bib0190","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.25609","article-title":"Genomic analysis of hepatic farnesoid X receptor binding sites reveals altered binding in obesity and direct gene repression by farnesoid X receptor in mice","volume":"56","author":"Lee","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2013.08.008_bib0195","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1210\/me.2003-0441","article-title":"Genome wide identification of high-affinity estrogen response elements in human and mouse","volume":"18","author":"Bourdeau","year":"2004","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.phrs.2013.08.008_bib0200","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1101\/gad.1709008","article-title":"PPARgamma and C\/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale","volume":"22","author":"Lefterova","year":"2008","journal-title":"Genes Dev"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366181300145X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366181300145X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T09:23:00Z","timestamp":1539422580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104366181300145X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":40,"alternative-id":["S104366181300145X"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2013.08.008","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FXR mediates a chromatin looping in the GR promoter thus promoting the resolution of colitis in rodents","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2013.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}